I think that is the most unlikely price it will close at.
It is still growing dose sales with numerous imminent clinical trails likely to results in a step change in dose sales as the product will most likely become standard of care instead of salvage.
Ann: Trading Update, page-115
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 17.5¢ | 17.5¢ | $290.8K | 1.662M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100853 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 1326027 | 33 |
View Market Depth
| Last trade - 15.53pm 29/08/2024 (20 minute delay) ? |
| SRX (ASX) Chart |